Literature DB >> 19590716

Current status of gynecologic cancer in Japan.

Kimio Ushijima1.   

Abstract

To make an overview of the current status of gynecologic cancer in Japan, we reviewed the recent incidence of cervical, endometrial, and ovarian cancer in Japanese women. The incidence of all three cancers has increased, but trends differ respectively. In age specific cancer site distribution data, the uterus and ovary are leading sites of high incidence among Japanese women younger than 40 years of age. Therefore, fertility sparing cancer treatment has received much attention. Several multicenter clinical trials have been done by Japanese groups, and some excellent evidence has been collected for endometrial and ovarian cancer. A promising international collaboration trial for ovarian clear cell carcinoma is also underway at the present time.

Entities:  

Keywords:  Adjuvant chemotherapy; Cervical cancer; Endometrial cancer; Epidemiology; Fertility preservation; Ovarian cancer

Year:  2009        PMID: 19590716      PMCID: PMC2705466          DOI: 10.3802/jgo.2009.20.2.67

Source DB:  PubMed          Journal:  J Gynecol Oncol        ISSN: 2005-0380            Impact factor:   4.401


  7 in total

1.  Conservative therapy for adenocarcinoma and atypical endometrial hyperplasia of the endometrium in young women: central pathologic review and treatment outcome.

Authors:  T Kaku; H Yoshikawa; H Tsuda; A Sakamoto; M Fukunaga; Y Kuwabara; M Hataeg; S Kodama; K Kuzuya; S Sato; T Nishimura; M Hiura; H Nakano; T Iwasaka; K Miyazaki; T Kamura
Journal:  Cancer Lett       Date:  2001-06-10       Impact factor: 8.679

2.  A phase II trial of weekly paclitaxel and every 3 weeks of carboplatin in potentially platinum-sensitive ovarian and peritoneal carcinoma.

Authors:  Peter G Rose; Mary Smrekar; Nancy Fusco
Journal:  Gynecol Oncol       Date:  2005-02       Impact factor: 5.482

3.  Clinical characteristics of clear cell carcinoma of the ovary: a distinct histologic type with poor prognosis and resistance to platinum-based chemotherapy.

Authors:  T Sugiyama; T Kamura; J Kigawa; N Terakawa; Y Kikuchi; T Kita; M Suzuki; I Sato; K Taguchi
Journal:  Cancer       Date:  2000-06-01       Impact factor: 6.860

4.  Adjuvant chemotherapy with irinotecan hydrochloride and cisplatin for clear cell carcinoma of the ovary.

Authors:  Masashi Takano; Yoshihiro Kikuchi; Nobuo Yaegashi; Mitsuaki Suzuki; Hiroshi Tsuda; Satoru Sagae; Yasuhiro Udagawa; Kazuo Kuzuya; Junzo Kigawa; Satoshi Takeuchi; Hitoshi Tsuda; Takuya Moriya; Toru Sugiyama
Journal:  Oncol Rep       Date:  2006-12       Impact factor: 3.906

5.  Randomized phase III trial of pelvic radiotherapy versus cisplatin-based combined chemotherapy in patients with intermediate- and high-risk endometrial cancer: a Japanese Gynecologic Oncology Group study.

Authors:  Nobuyuki Susumu; Satoru Sagae; Yasuhiro Udagawa; Kenji Niwa; Hiroyuki Kuramoto; Shinji Satoh; Ryuichi Kudo
Journal:  Gynecol Oncol       Date:  2007-11-09       Impact factor: 5.482

6.  Irinotecan (CPT-11) combined with cisplatin in patients with refractory or recurrent ovarian cancer.

Authors:  T Sugiyama; M Yakushiji; T Nishida; K Ushijima; N Okura; J Kigawa; N Terakawa
Journal:  Cancer Lett       Date:  1998-06-19       Impact factor: 8.679

7.  Multicenter phase II study of fertility-sparing treatment with medroxyprogesterone acetate for endometrial carcinoma and atypical hyperplasia in young women.

Authors:  Kimio Ushijima; Hideaki Yahata; Hiroyuki Yoshikawa; Ikuo Konishi; Toshiharu Yasugi; Toshiaki Saito; Toru Nakanishi; Hiroshi Sasaki; Fumitaka Saji; Tsuyoshi Iwasaka; Masayuki Hatae; Shoji Kodama; Tsuyoshi Saito; Naoki Terakawa; Nobuo Yaegashi; Masamichi Hiura; Atsuhiko Sakamoto; Hitoshi Tsuda; Masaharu Fukunaga; Toshiharu Kamura
Journal:  J Clin Oncol       Date:  2007-07-01       Impact factor: 44.544

  7 in total
  40 in total

1.  Salvage chemotherapy for recurrent or persistent clear cell carcinoma of the ovary: a single-institution experience for a series of 20 patients.

Authors:  Kiyoshi Yoshino; Takayuki Enomoto; Masami Fujita; Yutaka Ueda; Toshihiro Kimura; Eiji Kobayashi; Tateki Tsutsui; Tadashi Kimura
Journal:  Int J Clin Oncol       Date:  2011-12-10       Impact factor: 3.402

2.  Epidemiological characteristics of ovarian cancer in Korea.

Authors:  Boyoung Park; Sohee Park; Tae-Joong Kim; Seung Hyun Ma; Byoung-Gie Kim; Yong-Man Kim; Jae Weon Kim; Sokbom Kang; Jaehoon Kim; Tae Jin Kim; Keun-Young Yoo; Sue K Park
Journal:  J Gynecol Oncol       Date:  2010-12-31       Impact factor: 4.401

3.  Evidence-based guidelines for treatment of cervical cancer in Japan: Japan Society of Gynecologic Oncology (JSGO) 2007 edition.

Authors:  Satoru Nagase; Yoshiki Inoue; Naohiko Umesaki; Daisuke Aoki; Masatsugu Ueda; Hideki Sakamoto; Shigemitsu Kobayashi; Ryo Kitagawa; Takafumi Toita; Shoji Nagao; Kiyoshi Hasegawa; Ichio Fukasawa; Keiichi Fujiwara; Yoh Watanabe; Kiyoshi Ito; Hitoshi Niikura; Tsuyoshi Iwasaka; Kazunori Ochiai; Hidetaka Katabuchi; Toshiharu Kamura; Ikuo Konishi; Noriaki Sakuragi; Tadao Tanaka; Yasuo Hirai; Yuji Hiramatsu; Makio Mukai; Hiroyuki Yoshikawa; Tadao Takano; Kosuke Yoshinaga; Takeo Otsuki; Michiko Sakuma; Noriyuki Inaba; Yasuhiro Udagawa; Nobuo Yaegashi
Journal:  Int J Clin Oncol       Date:  2010-03-24       Impact factor: 3.402

4.  Telomere length in different histologic types of ovarian carcinoma with emphasis on clear cell carcinoma.

Authors:  Elisabetta Kuhn; Alan K Meeker; Kala Visvanathan; Amy L Gross; Tian-Li Wang; Robert J Kurman; Ie-Ming Shih
Journal:  Mod Pathol       Date:  2011-04-15       Impact factor: 7.842

5.  Asian Society of Gynecologic Oncology (ASGO): a central platform against gynecologic cancers in Asia.

Authors:  Soon-Beom Kang
Journal:  J Gynecol Oncol       Date:  2009-06-29       Impact factor: 4.401

6.  Difficulty in the management of pregnancy after vaginal radical trachelectomy.

Authors:  Sakura Takada; Shin-Ichi Ishioka; Toshiaki Endo; Tsuyoshi Baba; Miyuki Morishita; Yushi Akashi; Masahito Mizuuchi; Hidefumi Adachi; Miseon Kim; Tsuyoshi Saito
Journal:  Int J Clin Oncol       Date:  2012-10-03       Impact factor: 3.402

Review 7.  Epidemiology of Patients with Ovarian Cancer with and Without a BRCA1/2 Mutation.

Authors:  Elisabete Weiderpass; Jerzy E Tyczynski
Journal:  Mol Diagn Ther       Date:  2015-12       Impact factor: 4.074

8.  Changes of uterine blood flow after vaginal radical trachelectomy (VRT) in patients with early-stage uterine invasive cervical cancer.

Authors:  Kota Umemura; Shin-ichi Ishioka; Toshiaki Endo; Tsuyoshi Baba; Yoshiaki Ezaka; Kunihiko Nagasawa; Madoka Takahashi; Masahito Mizuuchi; Nanako Iwami; Hidefumi Adachi; Noriko Takeda; Mitsuharu Tamagawa; Tsuyoshi Saito
Journal:  Int J Med Sci       Date:  2010-08-05       Impact factor: 3.738

9.  Discrimination of malignant transformation from benign endometriosis using a near-infrared approach.

Authors:  Naoki Kawahara; Yuki Yamada; Fuminori Ito; Wataru Hojo; Takuya Iwabuchi; Hiroshi Kobayashi
Journal:  Exp Ther Med       Date:  2018-01-19       Impact factor: 2.447

10.  Candidate biomarkers for cervical cancer treatment: Potential for clinical practice (Review).

Authors:  Miho Iida; Kouji Banno; Megumi Yanokura; Kanako Nakamura; Masataka Adachi; Yuya Nogami; Kiyoko Umene; Kenta Masuda; Iori Kisu; Takashi Iwata; Kyoko Tanaka; Daisuke Aoki
Journal:  Mol Clin Oncol       Date:  2014-06-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.